Drug delivery

(ISSN: 1071-7544, 1521-0464)

Table of Contents

From Drug delivery

2021 - 28 (1)

  • Pharmacokinetics and efficacy of a ketorolac-loaded ocular coil in New Zealand white rabbits. 
  • Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential. 
  • Cerium oxide nanoparticle-loaded polyvinyl alcohol nanogels delivery for wound healing care systems on surgery. 
  • Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment. 
  • Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke. 
  • Fabrication of silver nanoparticles/gelatin hydrogel system for bone regeneration and fracture treatment. 
  • Enrofloxacin/florfenicol loaded cyclodextrin metal-organic-framework for drug delivery and controlled release. 
  • Development, optimization and characterization of nanoemulsion loaded with clove oil-naftifine antifungal for the management of tinea. 
  • Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology. 
  • Cubogel as potential platform for glaucoma management. 
  • Β-Cyclodextrin-graft-poly(amidoamine) dendrons as the nitric oxide deliver system for the chronic rhinosinusitis therapy. 
  • Stimuli-responsive drug delivery systems for head and neck cancer therapy. 
  • Theoretical model for the diclofenac release from PEGylated chitosan hydrogels. 
  • A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis. 
  • Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability. 
  • RPE-derived exosomes rescue the photoreceptors during retina degeneration: an intraocular approach to deliver exosomes into the subretinal space. 
  • Local anesthetic lidocaine-encapsulated polymyxin-chitosan nanoparticles delivery for wound healing: in vitro and in vivo tissue regeneration. 
  • A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver. 
  • Ocular lamellar crystalline gels for sustained release and enhanced permeation of resveratrol against corneal neovascularization. 
  • A novel redox-responsive ursolic acid polymeric prodrug delivery system for osteosarcoma therapy. 
  • Anti-tumor effect of local injectable hydrogel-loaded endostatin alone and in combination with radiotherapy for lung cancer. 
  • Preservation of small extracellular vesicles for functional analysis and therapeutic applications: a comparative evaluation of storage conditions. 
  • Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α. 
  • Simulating drug penetration during hyperthermic intraperitoneal chemotherapy. 
  • Preparation and evaluation of conjugate nanogels of glycyl-prednisolone with natural anionic polysaccharides as anti-arthritic delivery systems. 
  • L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent. 
  • The relevance of nanotechnology, hepato-protective agents in reducing the toxicity and augmenting the bioavailability of isotretinoin. 
  • Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus. 
  • Development of local anesthetic drug delivery system by administration of organo-silica nanoformulations under ultrasound stimuli: in vitro and in vivo investigations. 
  • Management of recurrent aphthous ulcers exploiting polymer-based Muco-adhesive sponges: in-vitro and in-vivo evaluation. 
  • Model-based optimized steering and focusing of local magnetic particle concentrations for targeted drug delivery. 
  • Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design: in vitro characterization and in vivo evaluation. 
  • The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials. 
  • Progress in the development of stabilization strategies for nanocrystal preparations. 
  • Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery. 
  • Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: in-vitro characterization, statistical optimization, and in-vivo assessment. 

Journal Information